Delivery Order SPE2DB20D3103-SPE2DB22FN7D3
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award, valued at $2,507.33, is for the delivery of Metoprolol Succinate Extended-Release 100 mg tablets in 100-count bottles. The contract is a Firm Fixed Price Delivery Order with a completion date of September 28, 2023. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp, a major pharmaceutical...
- The federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,524.41 firm-fixed-price delivery order is for the supply of 4,562,700 units of Metoprolol Succinate Extended-Release 50 mg tablets. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,498.60, is a delivery order for the supply of Metoprolol Succinate Extended-Release 100 mg Tablets. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and is not set aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- This federal contract award, valued at $3,085.78, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award is a Delivery Order contract for the supply of Metoprolol Succinate Extended-Release 50 mg tablets. The contract has a period of performance through January 4, 2024 and uses a Firm Fixed Price pricing type. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award, valued at $1,098.72, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of 4,568,076,308 units of Metoprolol Succinate Extended-Release 100 mg Tablets. The contract has a performance period extending through April 30, 2025 and is priced on a firm-fixed-price basis. AmerisourceBergen Drug Corp holds a significant...
- This federal contract award, valued at $3,718.41, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Metoprolol Succinate ER 50 mg tablets in quantities of 1,000. This is a firm-fixed-price delivery order contract with an ultimate completion date of March 7, 2024. The contract was awarded on March 6, 2024 and is not designated as a set-aside. Amerisourcebergen Drug...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,076.75 firm fixed-price contract is for the delivery of 4,564,542,315 units of Metoprolol Succinate ER 50 mg tablets. The contract has an ultimate completion date of May 9, 2024. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,363.91 Firm Fixed Price Delivery Order (SPE2DB20D2002|SPE2DB23FL50N) is for the supply of Metoprolol Succinate Extended-Release 25 mg Tablets in 1000-count packaging. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora,...
- This federal contract award, with an ID of SPE2DB20D3101|SPE2DB22FH3P9, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $6,995.59 contract is for the delivery of 4,555,791,284 units of Metoprolol Succinate Extended-Release 25 mg tablets. The contract has no set-aside designation, indicating it was competitively awarded. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,743.51 firm fixed-price delivery order is for the supply of 4,559,461,647 units of Metoprolol Succinate ER 25 mg tablets. The award has an ultimate completion date of December 29, 2022 and was made on December 28, 2022. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB22FN7D3Delivery Order
This federal contract award, with ID SPE2DB20D3103|SPE2DB22FN7D3, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,899.56 delivery order is for the supply of Metoprolol Succinate ER 50 mg tablets in 1,000-count packages. The contract has a firm fixed price and an ultimate completion date of May 24, 2022. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026. This IDC enables the company to efficiently deliver a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 5/23/22 |